recent publications

• academic article

  • Amelio, A. L., Fallahi, M., Schaub, F. X., Zhang, M., Lawani, M. B., Alperstein, A. S., Southern, M. R., Young, B. M., Wu, L., Zajac-Kaye, M., Kaye, F. J., Cleveland, J. L., et al. CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement Proceedings of the National Academy of Sciences of the United States of America  2014 111:E3260-E3268  DOI:10.1073/pnas.1319176111  PMID:25071166  PMCID:PMC4136562
  • Bonsignori, M., Hwang, K. K., Chen, X., Tsao, C. Y., Morris, L., Gray, E., Marshall, D. J., Crump, J. A., Kapiga, S. H., Sam, N. E., Sinangil, F., Pancera, M., et al. Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors Journal of Virology  2011 85:9998-10009  DOI:10.1128/jvi.05045-11  PMID:21795340  PMCID:PMC3196428
  • Wu, X. L., Zhou, T. Q., Zhu, J., Zhang, B. S., Georgiev, I., Wang, C., Chen, X. J., Longo, N. S., Louder, M., McKee, K., O'Dell, S., Perfetto, S., et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing Science  2011 333:1593-1602  DOI:10.1126/science.1207532  PMID:21835983  PMCID:PMC3516815
  • Liu, S. J., Yu, Z. H., Yu, X. A., Huang, S. X., Luo, Y. G., Wu, L., Shen, W. H., Yang, Z. Y., Wang, L. N., Gunawan, A. M., Chan, R. J., Shen, B., et al. Shp2 is a target of the immunosuppressant tautomycetin Chemistry & Biology  2011 18:101-110  DOI:10.1016/j.chembiol.2010.10.015  PMID:21276943  PMCID:PMC3034256
  • Wu, X. L., Yang, Z. Y., Li, Y. X., Hogerkorp, C. M., Schief, W. R., Seaman, M. S., Zhou, T. Q., Schmidt, S. D., Wu, L., Xu, L., Longo, N. S., McKee, K., et al. Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to hiv-1 Science  2010 329:856-861  DOI:10.1126/science.1187659  PMID:20616233  PMCID:PMC2965066
  • Wu, L., Zhou, T. Q., Yang, Z. Y., Svehla, K., O'Dell, S., Louder, M. K., Xu, L., Mascola, J. R., Burton, D. R., Hoxie, J. A., Doms, R. W., Kwong, P. D., et al. Enhanced exposure of the cd4-binding site to neutralizing antibodies by structural design of a membrane-anchored human immunodeficiency virus type 1 gp120 domain Journal of Virology  2009 83:5077-5086  DOI:10.1128/jvi.02600-08  PMID:19264769  PMCID:PMC2682083
  • Suzuki, H., Forrest, A. R. R., van Nimwegen, E., Daub, C. O., Balwierz, P. J., Irvine, K. M., Lassmann, T., Ravasi, T., Hasegawa, Y., de Hoon, M. J. L., Katayama, S., Schroder, K., et al. The transcriptional network that controls growth arrest and differentiation in a human myeloid leukemia cell line Nature Genetics  2009 41:553-562  DOI:10.1038/ng.375  PMID:19377474
  • Lieberson, R., Mowen, K. A., McBride, K. D., Leautaud, V., Zhang, X. K., Suh, W. K., Wu, L., Glimcher, L. H. Tumor necrosis factor receptor-associated factor (TRAF)2 represses the T helper cell type 2 response through interaction with NFAT-interacting protein (NIP45) Journal of Experimental Medicine  2001 194:89-98  DOI:10.1084/jem.194.1.89  PMID:11435475  PMCID:PMC2193447
  • Baldwin, K. K., Reay, P. A., Wu, L., Farr, A., Davis, M. M. A T cell receptor-specific blockade of positive selection Journal of Experimental Medicine  1999 189:13-23  DOI:10.1084/jem.189.1.13  PMID:9874560  PMCID:PMC1887687
  • Wu, L., Pearse, M., Egerton, M., Petrie, H., Scollay, R. CD4-CD8- thymocytes that express the T-cell receptor may have previously expressed CD8 International Immunology  1990 2:51-56  DOI:10.1093/intimm/2.1.51  PMID:2150920